Trilostane
ATC Code
H02CA01
Trilostane
Definition
A synthetic derivative of androstane with adrenocortical suppressive properties. Trilostane reversibly inhibits 3 beta-hydroxysteroid dehydrogenase delta 5-4 isomerase in the adrenal cortex, resulting in the decreased synthesis of mineralocorticoids and glucocorticoids and the decreased conversion of pregnenolone to progesterone. (NCI04)
Also known as (4Alpha,5alpha,17beta)-4,5-epoxy-3,17-dihydroxyandrost-2-ene-2-carbonitrile, 2Alpha-cyano-4alpha,5alpha-epoxyandrostan-17beta-ol-3-one, 4,5-Epoxy-17-hydroxy-3-oxoandrostane-2-carbonitrile, Desopan, Modrastane, Modrenal, TRILOSTANE, WIN 24,540, WIN 24540 — per NCIT
Also identified as
- ATC H02CA01 per RXNORM
- NCIT NCIT:C1263 per NCIT
- SCTID 25142008 per RXNORM
- SCTID 387134000 per RXNORM
- UNII L0FPV48Q5R per RXNORM